Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
Ocrelizumab prevented disease activity over the long term and its effect on the immune system did not determine a significant infection risk in most patients.
Authors
- Tommaso Guerra (ORCID: https://orcid.org/0000-0002-5248-5981)
- Pietro Iaffaldano (ORCID: https://orcid.org/0000-0003-2308-1731)
- Francesca Caputo (ORCID: https://orcid.org/0000-0002-6734-0523)
- Damiano Paolicelli (ORCID: https://orcid.org/0000-0002-8645-1763)
- Antonella Bianco
Institutions
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1007/s40801-025-00486-x
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 3.34